234 related articles for article (PubMed ID: 18418794)
1. Cigarette smoking is an independent predictor of nonadherence in HIV-infected individuals receiving highly active antiretroviral therapy.
Shuter J; Bernstein SL
Nicotine Tob Res; 2008 Apr; 10(4):731-6. PubMed ID: 18418794
[TBL] [Abstract][Full Text] [Related]
2. Factors influencing medication adherence beliefs and self-efficacy in persons naive to antiretroviral therapy: a multicenter, cross-sectional study.
Reynolds NR; Testa MA; Marc LG; Chesney MA; Neidig JL; Smith SR; Vella S; Robbins GK;
AIDS Behav; 2004 Jun; 8(2):141-50. PubMed ID: 15187476
[TBL] [Abstract][Full Text] [Related]
3. Medication adherence in HIV-infected smokers: the mediating role of depressive symptoms.
Webb MS; Vanable PA; Carey MP; Blair DC
AIDS Educ Prev; 2009 Jun; 21(3 Suppl):94-105. PubMed ID: 19537957
[TBL] [Abstract][Full Text] [Related]
4. Psychosocial determinants of adherence to highly active antiretroviral therapy among injection drug users in Vancouver.
Kerr T; Palepu A; Barness G; Walsh J; Hogg R; Montaner J; Tyndall M; Wood E
Antivir Ther; 2004 Jun; 9(3):407-14. PubMed ID: 15259903
[TBL] [Abstract][Full Text] [Related]
5. Evidence-based, multifactorial approach to addressing non-adherence to antiretroviral therapy and improving standards of care.
Herrmann S; McKinnon E; John M; Hyland N; Martinez OP; Cain A; Turner K; Coombs A; Manolikos C; Mallal S
Intern Med J; 2008 Jan; 38(1):8-15. PubMed ID: 17916167
[TBL] [Abstract][Full Text] [Related]
6. Adherence to highly active antiretroviral therapy predicts virologic outcome at an inner-city human immunodeficiency virus clinic.
McNabb J; Ross JW; Abriola K; Turley C; Nightingale CH; Nicolau DP
Clin Infect Dis; 2001 Sep; 33(5):700-5. PubMed ID: 11486292
[TBL] [Abstract][Full Text] [Related]
7. Predictors of adherence to antiretroviral medications in children and adolescents with HIV infection.
Williams PL; Storm D; Montepiedra G; Nichols S; Kammerer B; Sirois PA; Farley J; Malee K;
Pediatrics; 2006 Dec; 118(6):e1745-57. PubMed ID: 17101712
[TBL] [Abstract][Full Text] [Related]
8. Antiretroviral medication adherence among the REACH HIV-infected adolescent cohort in the USA.
Murphy DA; Wilson CM; Durako SJ; Muenz LR; Belzer M;
AIDS Care; 2001 Feb; 13(1):27-40. PubMed ID: 11177463
[TBL] [Abstract][Full Text] [Related]
9. Utility of the Millon Behavioral Medicine Diagnostic (MBMD) to predict adherence to highly active antiretroviral therapy (HAART) medication regimens among HIV-positive men and women.
Cruess DG; Minor S; Antoni MH; Millon T
J Pers Assess; 2007 Dec; 89(3):277-90. PubMed ID: 18001228
[TBL] [Abstract][Full Text] [Related]
10. Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women.
Kapadia F; Vlahov D; Wu Y; Cohen MH; Greenblatt RM; Howard AA; Cook JA; Goparaju L; Golub E; Richardson J; Wilson TE
Am J Drug Alcohol Abuse; 2008; 34(2):161-70. PubMed ID: 18293232
[TBL] [Abstract][Full Text] [Related]
11. HIV-infected pregnant women have greater adherence with antiretroviral drugs than non-pregnant women.
Vaz MJ; Barros SM; Palacios R; Senise JF; Lunardi L; Amed AM; Castelo A
Int J STD AIDS; 2007 Jan; 18(1):28-32. PubMed ID: 17326859
[TBL] [Abstract][Full Text] [Related]
12. Received social support, self-efficacy, and finding benefits in disease as predictors of physical functioning and adherence to antiretroviral therapy.
Luszczynska A; Sarkar Y; Knoll N
Patient Educ Couns; 2007 Apr; 66(1):37-42. PubMed ID: 17097259
[TBL] [Abstract][Full Text] [Related]
13. Adherence to HAART therapy measured by electronic monitoring in newly diagnosed HIV patients in Botswana.
Vriesendorp R; Cohen A; Kristanto P; Vrijens B; Rakesh P; Anand B; Iwebor HU; Stiekema J
Eur J Clin Pharmacol; 2007 Dec; 63(12):1115-21. PubMed ID: 17882408
[TBL] [Abstract][Full Text] [Related]
14. [Factors associated with adherence to therapy among HIV-infected patients in Bangui].
Mouala C; Kaba-Mebri J; Wata JB; Rey JL
Sante; 2006; 16(2):119-30. PubMed ID: 17116636
[TBL] [Abstract][Full Text] [Related]
15. Predicting and monitoring antiretroviral adherence.
Gross R
LDI Issue Brief; 2007; 13(2):1-4. PubMed ID: 18354853
[TBL] [Abstract][Full Text] [Related]
16. Patient and regimen characteristics associated with self-reported nonadherence to antiretroviral therapy.
Sullivan PS; Campsmith ML; Nakamura GV; Begley EB; Schulden J; Nakashima AK
PLoS One; 2007 Jun; 2(6):e552. PubMed ID: 17579723
[TBL] [Abstract][Full Text] [Related]
17. Poor adherence to HIV monitoring and treatment guidelines for HIV-infected injection drug users.
Wood E; Kerr T; Zhang R; Guillemi S; Palepu A; Hogg RS; Montaner JS
HIV Med; 2008 Aug; 9(7):503-7. PubMed ID: 18484977
[TBL] [Abstract][Full Text] [Related]
18. Lipodystrophy severity does not contribute to HAART nonadherence.
Collins EJ; Burgoyne RW; Wagner CA; Abbey SE; Halman MH; Nur ML; Walmsley SL
AIDS Behav; 2006 May; 10(3):273-7. PubMed ID: 16421650
[TBL] [Abstract][Full Text] [Related]
19. Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, 1994-2005.
Buchacz K; Baker RK; Moorman AC; Richardson JT; Wood KC; Holmberg SD; Brooks JT;
AIDS; 2008 Jul; 22(11):1345-54. PubMed ID: 18580614
[TBL] [Abstract][Full Text] [Related]
20. The role of anger in adherence to highly active antiretroviral treatment in patients infected with HIV.
Leombruni P; Fassino S; Lavagnino L; Orofino G; Morosini P; Picardi A
Psychother Psychosom; 2009; 78(4):254-7. PubMed ID: 19468260
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
